Journal article Open Access

Metabolic Syndrome and Risk of Colorectal Adenoma and Colorectal Cancer: A Meta-Analysis

ElHarag Salah Eddine; Youssouf Traoré; Meghit Boumediene Khaled

DataCite XML Export

<?xml version='1.0' encoding='utf-8'?>
<resource xmlns:xsi="" xmlns="" xsi:schemaLocation="">
  <identifier identifierType="DOI">10.5281/zenodo.1245604</identifier>
      <creatorName>ElHarag Salah Eddine</creatorName>
      <affiliation>Djillali Liabes University of Sidi Bel Abbes</affiliation>
      <creatorName>Youssouf Traoré</creatorName>
      <affiliation>Djillali Liabes University of Sidi Bel Abbes</affiliation>
      <creatorName>Meghit Boumediene Khaled</creatorName>
      <affiliation>Djillali Liabes University of Sidi Bel Abbes</affiliation>
    <title>Metabolic Syndrome and Risk of Colorectal Adenoma and Colorectal Cancer: A Meta-Analysis</title>
    <subject>Metabolic syndrome</subject>
    <subject>Colorectal cancer</subject>
    <subject>Colorectal adenoma</subject>
    <date dateType="Issued">2017-10-28</date>
  <resourceType resourceTypeGeneral="Text">Journal article</resourceType>
    <alternateIdentifier alternateIdentifierType="url"></alternateIdentifier>
    <relatedIdentifier relatedIdentifierType="DOI" relationType="IsVersionOf">10.5281/zenodo.1245603</relatedIdentifier>
    <rights rightsURI="">Creative Commons Attribution 4.0 International</rights>
    <rights rightsURI="info:eu-repo/semantics/openAccess">Open Access</rights>
    <description descriptionType="Abstract">&lt;p&gt;BACKGROUND: Growing evidence suggests that metabolic syndrome (MetS) could be linked with the incidence of colorectal adenoma and cancer (CRA and CRC). AIMS: Conducting a metaanalysis to assess the association of MetS with both CRA and CRC. METHODS AND MATERIAL: Relevant studies were identified by systematically searching PubMed database for articles published in the last ten years. A random effect analysis model and Mantel-Haenszel statistical method were used to obtain pooled risk ratios (RRs) and their 95% confidence intervals (CIs) for dichotomous data. The analyses were assessed for heterogeneity and publication bias. RESULTS: 35 studies were included in the meta-analysis involving approximately 1300000 participants. A significant high risk for CRA was observed among patients with MetS compared to those without (RR = 1.43; 95% CI = 1.31, 1.57). The pooled RRs of CRC were 1.46 (95% CI = 1.36, 1.56). The risk estimates varied according to the type of the study (cohorts and non-cohorts), gender (men and women), MetS definition (NCEP-ATPIII, IDF, harmonized and others), populations (Asia, Europe, and the USA), and cancer location (colon and rectum). CONCLUSIONS: MetS is associated with an increased risk of CRA and CRC. The risk was higher for advanced adenomas. Taking into consideration MetS patients in the secondary prevention programs and the management of this&lt;br&gt;
condition in the aim of the primary prevention is highly recommended.&lt;/p&gt;</description>
All versions This version
Views 8181
Downloads 1818
Data volume 12.0 MB12.0 MB
Unique views 7373
Unique downloads 1616


Cite as